| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/NYAS.12034 |
| P698 | PubMed publication ID | 23384346 |
| P2093 | author name string | Narinder K Mehra | |
| Gurvinder Kaur | |||
| Sanjeev Goswami | |||
| Ajay Baranwal | |||
| Jamshaid Siddiqui | |||
| P2860 | cites work | Detection and clinical relevance of donor specific HLA antibodies: a matter of debate | Q26998713 |
| Abrogation of anti-HLA antibodies via proteasome inhibition | Q33384617 | ||
| Direct and indirect antigen recognition: the pathways to allograft immune rejection | Q33637334 | ||
| Impact of pretransplant human leukocyte antigen-C and -DP antibodies on kidney graft outcome. | Q54338277 | ||
| Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome | Q58836886 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Antibody-mediated rejection in kidney transplantation: a review | Q35915453 | ||
| Humoral theory of transplantation: further evidence | Q36228533 | ||
| Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection | Q36843420 | ||
| Antibody mediated rejection: update 2006. | Q36910384 | ||
| De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact. | Q37323149 | ||
| Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient | Q37425991 | ||
| Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications | Q37853627 | ||
| Non-human leukocyte antigen antibodies reactive with endothelial cells could be involved in early loss of renal allografts. | Q39534801 | ||
| Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? | Q39596692 | ||
| Effector mechanisms in allograft rejection | Q39733280 | ||
| Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal | Q39824383 | ||
| Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation | Q39979381 | ||
| Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure | Q40386334 | ||
| MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. | Q41069294 | ||
| Major histocompatibility complex class 1 chain-related antigen a antibodies: sensitizing events and impact on renal graft outcomes | Q42171607 | ||
| Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades | Q42627664 | ||
| Preformed donor HLA-DP-specific antibodies mediate acute and chronic antibody-mediated rejection following renal transplantation | Q42838879 | ||
| Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection | Q43166691 | ||
| Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques | Q43618124 | ||
| Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report | Q43937861 | ||
| Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. | Q44092564 | ||
| Rituximab as treatment for refractory kidney transplant rejection | Q44899030 | ||
| Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification | Q44919347 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction | Q45309367 | ||
| Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. | Q46038626 | ||
| Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation | Q46429084 | ||
| Predictive value of HLA antibodies and serum creatinine in chronic rejection: results of a 2-year prospective trial | Q46825301 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Molecular diversity of HLA-A*02 in Asian Indians: predominance of A*0211. | Q47889897 | ||
| Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant | Q47989417 | ||
| Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. | Q50618048 | ||
| Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
| Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. | Q50765005 | ||
| Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation. | Q50790533 | ||
| HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. | Q51052051 | ||
| Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. | Q51094516 | ||
| Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival. | Q51794444 | ||
| Chronic humoral rejection mediated by anti-HLA-DP alloantibodies: insights into the role of epitope sharing in donor-specific and non-donor specific alloantibodies generation. | Q51959096 | ||
| Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. | Q52668051 | ||
| Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Q53243295 | ||
| Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. | Q54013696 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 30-42 | |
| P577 | publication date | 2013-02-05 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Clinical relevance of antibody development in renal transplantation | |
| P478 | volume | 1283 |
| Q41192310 | Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report |
| Q37252505 | Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching |
| Q61945632 | Analysis of Specificity of Anti–Human Leukocyte Antigen Antibodies in Kidney Recipients in Reference to Clinical Outcome |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q33882783 | Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation |
| Q92055953 | Follicular helper T cells and humoral response in organ transplantation |
| Q38216381 | Graft microvascular disease in solid organ transplantation |
| Q42364236 | IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment of Patients With Early Donor Specific Anti-HLA Antibodies After Lung Transplantation |
| Q39178552 | Major Histocompatibility Complex Class I Chain-Related A (MICA) Molecules: Relevance in Solid Organ Transplantation |
| Q38262909 | Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation |
| Q59807111 | Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential |
| Q41889413 | Presensitization revisited: pitfalls of vascular allografts in transplant candidates. |
| Q42434636 | Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition. |
Search more.